Study Overview: This study is testing a new treatment called EVO756 for adults with a skin condition called chronic inducible urticaria. This condition causes itchy welts or hives that can be triggered by things like scratching or cold temperatures.
Key Details: The study is in phase 2a, which means it is early in testing to check if EVO756 is safe and works well. People can join if they have had this condition for at least 3 months and show a reaction to certain tests.
Who Can Join: You can participate if diagnosed with chronic inducible urticaria for at least 3 months. You will need to show a reaction to tests that make the condition appear. However, if you have other similar skin conditions or take certain medications, you might not be eligible.
- Length: The study lasts several weeks with regular check-ups.
- Visits: Participants will need to visit the study center multiple times.
- Compensation: Participants may receive compensation for their time and travel.
Consider joining if you meet the criteria and want to contribute to potential new treatments for this skin condition.